Teleflex Incorporated, a recognized global leader in medical technologies, recently conducted a multinational study on its Arrow™ Chlorhexidine-Impregnated Central Venous Catheters (CVCs). The study results lend substantial clinical validation to the product, revealing an impressive 70.5% reduction in CLABSI (central line-associated bloodstream infections) - a percentage derived from a robust sample size of more than…
The elevation in risk of infection due to methicillin-resistant Staphylococcus aureus (MRSA) colonization necessitates the use of precise detection methods which can significantly impact postoperative outcomes and extend a patient's hospital stay. Utilizing conventional culture methods for MRSA detection has proven to be restrictive due to sensitivity issues and slower processing time. Consequently, a tertiary…